Back to top

Education programme aimed at increasing physical activity in individuals with diagnosed coronary heart disease (PACES study)

Developing and evaluating an education programme aimed at increasing physical activity in individuals with diagnosed coronary heart disease: a randomised controlled trial (PACES study)

What we are doing:

The aim of this study is to assess the effectiveness of an education programme delivered to participants 12 to 48 months after being diagnosed with coronary heart disease (CHD), to increase physical activity in order to reduce subsequent risk of cardiovascular disease (CVD). An intervention has been developed which will consist of group structured education reinforced by text messaging. Patient-related outcome measures include physical activity, satisfaction and wellbeing. The primary outcome is physical activity. Secondary outcomes include cardiovascular risk factors such as blood pressure, body composition and lipid profile.

Why are we doing it:

CHD represents approximately 13% of deaths worldwide and is the leading cause of death in the United Kingdom with considerable associated healthcare costs. Following a CHD event such as a heart attack, patients are far more likely to experience a further event unless there are interventions to target risk factors such as obesity, diabetes, hypertension, hyperlipidaemia and smoking. After a heart attack or other cardiac event, patients are offered a short period, usually 6 weeks, of intensive cardiac rehabilitation. Subsequently, risk factor management is carried out in primary care where it can be of variable quality and quantity. The optimal strategy for CHD risk reduction in these patients needs to be examined further before widespread national recommendations can be made.

What the benefits will be:

If proved effective, the programme could be a feasible, acceptable and cost-effective strategy for increasing physical activity levels in individuals with diagnosed coronary heart disease.

Who we are working with:

The study will be conducted with the support of:

  • Leicester Clinical Commissioning Group (CCG)
  • Leicestershire Clinical Commissioning Groups (CCG)
  • University of Leicester
  • University Hospitals of Leicester NHS Trust

Study lead:

Professor Melanie Davies, Professor of Diabetes Medicine, University of Leicester


Louisa Herring,